Wellnex Life Limited (AIM:WNX)

London flag London · Delayed Price · Currency is GBP · Price in GBX
5.02
-1.98 (-28.29%)
Apr 16, 2026, 10:29 AM GMT
Market Cap2.81M -74.8%
Revenue (ttm)12.18M +6.3%
Net Income-4.89M
EPS-0.10
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume33,000
Average Volume1,375
Open6.00
Previous Close7.00
Day's Range5.02 - 6.00
52-Week Range5.00 - 19.00
Betan/a
RSI6.55
Earnings DateMay 27, 2026

About Wellnex Life

Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life bran... [Read more]

Founded 2011
Country Australia
Stock Exchange London Stock Exchange AIM
Ticker Symbol WNX

Financial Performance

In fiscal year 2025, Wellnex Life's revenue was 23.63 million, an increase of 40.39% compared to the previous year's 16.83 million. Losses were -15.60 million, 13.6% more than in 2024.

Financial numbers in AUD Financial Statements